May 05, 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Mar 24, 2020
Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine® in Patients with COVID-19 Associated Respiratory Illness
Nov 27, 2019
The Erythropoietin Stimulating Agents Market in Latin America (2019-2027): Data on Epoetin-Alfa, Epoetin-Beta, Epoetin-Theta, Darbepoetin-Alfa, and Other ESAs
Oct 07, 2019
Helixmith shows long-term safety and efficacy of VM202 for painful DPN patients in DPN phase 3-1b extension study
Sep 20, 2019
Global Neutropenia Treatment Market Report 2019-2027
Sep 19, 2019
Partner Therapeutics Receives Orphan Drug Designation for Leukine® (sargramostim)
Sep 16, 2019
China Recombinant Human Thrombopoietin Markets, 2013-2017, 2017-2018 & 2019-2023
Jun 26, 2019
Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) Overview 2019: An Oral Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1), VEGFR-2, & VEGFR-3
Jun 24, 2019
Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist
Apr 08, 2019
IGF Oncology Appoints Gary G. Altman, Ph.D., as Chief Executive Officer
Mar 27, 2019
BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
Mar 25, 2019
AlzeCure to Present at International Scientific Conference
Feb 28, 2019
Patient access to cost-effective treatments increased with launch of new biosimilar in Canada
Feb 17, 2019
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients
Jan 14, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat(TM) for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital
Sep 28, 2018
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration
Sep 21, 2018
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Aug 07, 2018
BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization
Jul 31, 2018
Pfizer's Retacrit, the First Erythropoietin Stimulating Agent to be FDA Approved, Not Likely to See Rapid Adoption in the US Dialysis Market
Jul 13, 2018
Cerapedics Announces Closing of $22 Million Financing